Even the big investors are short on money! Abu Dhabi sovereign fund sells off billions of dollars in US stock holdings
Abu Dhabi sovereign funds have been intensively selling off their holdings, cashing out billions of dollars at the market peak.
This Tuesday, Mubadala Investment Co. offloaded shares of the chip manufacturer GlobalFoundries through a block trade, raising approximately $1.9 billion.
Abu Dhabi Investment Authority (ADIA), on the other hand, cashed out $273 million through the sale of its shares in the medical supplier Medline.
These actions to reduce holdings come at a time when global stock market sentiment continues to heat up. Since its low in March, the S&P 500 index has risen more than 19%, providing a favorable window for sovereign funds to lock in profits.

Intensive Profit-Taking, Multiple Deals in Quick Succession
Mubadala completed a block trade of GlobalFoundries on Tuesday night, cashing in around $1.9 billion.
In a statement, Mubadala said that GlobalFoundries remains an important long-term investment for the fund, and that it continues to hold a 73% stake in the company after the sale.
Mubadala stated that it “highly recognizes” GlobalFoundries’ strategic direction and believes that broadening the shareholder base will further strengthen the company’s market position.
Meanwhile, Medline’s major shareholders completed a stock sale last weekend, raising $273 million for Abu Dhabi Investment Authority.
This marks ADIA’s second cash-out from Medline this year, having previously raised $253 million through a sell-down (including the greenshoe option) in March.
On the same day, power equipment company Innio set terms for its $2 billion IPO, from which Abu Dhabi Investment Authority, as a significant minority shareholder in Innio’s parent company, will see considerable returns.
Despite the large-scale profit-taking, Abu Dhabi’s sovereign funds remain actively deploying into new assets.
Last week, Abu Dhabi Investment Authority participated in CVC Capital Partners Plc’s acquisition offer for Italian pharma company Recordati SpA, which valued Recordati at approximately 10.7 billion euros (about $12.4 billion).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
JPMorgan anticipates earnings season for Japanese IT services and telecommunications: cybersecurity in focus, under-the-radar stocks poised for breakout
J.P. Morgan analyst Matthew Henderson has released his latest research report, providing a comprehensive outlook on the upcoming quarterly financial results (July to September) for Japan's IT services and telecommunications industry.
Don’t Just Focus on the Tech Sector! Goldman Sachs Bets on These 10 Energy Stocks, Up as Much as 151% This Year and Still Recommends Buying
Goldman Sachs has identified four main investment themes and selected 10 stocks with attractive risk-reward profiles within the integrated energy and power sector.
Trump Entered Before Muse AI's Surge! Accurate Meta and SpaceX Rebound Trades in August, Bought SpaceX Bonds Ahead of New Aerospace Policies
In August, Trump's account conducted 517 securities transactions with a total transaction amount of approximately $74.3 million to $273.3 million, including the purchase of $5 million to $25 million worth of Meta stock.
